Neurology News

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of the SJMB12 (NCT01878617) trial.

Published data showed psychological symptoms following sport-related concussions are common in high school athletes and may delay their recovery.

Improvements in “on” time were observed as early as day 3 after treatment initiation with an investigational subcutaneous combination therapy for Parkinson’s disease, which also led to significant improvement by day 7, data show.

Ajovy offers “significant efficacy” compared with placebo to address episodic migraine in children and adolescents, according to topline results from the phase 3 SPACE study.

Lantheus Holdings Inc. has announced the acquisition of Meilleur Technologies Inc., which includes the transfer of its rights to an amyloid-beta positron emission tomography imaging agent.

Autism spectrum disorder incidence was higher for children with prenatal exposure to antiseizure medications vs. the general population, but some associations weakened after adjusting for treatment indication, researchers reported.

Epilepsy was common in two urban Kenyan settings and diagnostic gaps were substantially high, demonstrating a need for targeted interventions, according to research in The Lancet Global Health.

Semaglutide was not associated with increased risks for adverse neurologic or psychological disorders at 1 year compared with other diabetes drugs, according to data published in eClinicalMedicine.

It’s only the beginning.

NEW YORK — In this Healio Video Perspective from the American Psychiatric Association Annual Meeting, Stefanie Simmons, MD, FACEP, chief medical officer of the Dr. Lorna Breen Heroes’ Foundation, discusses the Frontline Connect toolkit.